Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker.
Saved in:
| Title: | Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker. |
|---|---|
| Authors: | Pearson, A.L.1, Jin, W.2, Mellon, E.A.3, Frakes, J.M.3, Strom, T.3, Springett, G.M.3, Kim, R.4, Mahipal, A.3, Hodul, P.J.3, Pimiento, J.M.3, Shridhar, R.3, Malafa, M.P.3, Hoffe, S.E.3 |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE153-E153. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
